My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Uber Technologies Inc Health care industry
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags AstraZeneca PLC Health care industry World News
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Business Hims & Hers Health Inc Breaking News: Technology
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Eli Lilly and Co Biotech and Pharmaceuticals Health & Science
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Healthy Returns Social issues Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Business News Health care industry Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Healthy Returns Apple Inc Novo Nordisk A/S
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Business News Pharmaceuticals Biotechnology
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Health care industry Biotechnology Novo Nordisk A/S
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Breaking news Companies US: News
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Policy Politics Congress
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Biotech and Pharmaceuticals Health & Science Companies
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Starbucks Corp Business News Constellation Brands Inc
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Companies Breaking news Business
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Eli Lilly and Co Biotech and Pharmaceuticals Health & Science
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Business US: News Social issues
From CNBC.com News
Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
Tags Novo Nordisk A/S Biotechnology Health care industry
From CNBC.com News
Danone CEO downplays threat of weight loss drugs on food producers: 'We see ourselves as extremely complementary'
Tags Food and drink Danone SA Business News
From CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
Tags Healthy Returns Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Altimmune says weight loss drug minimized muscle loss in trial results that may set it apart
Tags US: News Business Companies
From CNBC.com News
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Viking Therapeutics stock jumps 15% on promising weight loss pill data
Tags Eli Lilly and Co Health & Science Science
From CNBC.com News
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
Two fresh ways to play the weight loss and megacap tech hype
Tags Finance Weight loss diets Personal investing
From CNBC.com News
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Tags Companies US: News Social issues
From CNBC.com News
Cramer's Lighting Round: Arm is a buy
Tags Arm Holdings PLC Raymond James Financial Inc Uber Technologies Inc
From CNBC.com News
Medicare can now cover certain weight loss drugs in a big step for patients
Tags Social issues US: News Business
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Viking Therapeutics Inc Merck & Co Inc Akero Therapeutics Inc
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.